US20060228814A1 - Electrochemical immunoassays using colloidal metal markers - Google Patents

Electrochemical immunoassays using colloidal metal markers Download PDF

Info

Publication number
US20060228814A1
US20060228814A1 US11/386,654 US38665406A US2006228814A1 US 20060228814 A1 US20060228814 A1 US 20060228814A1 US 38665406 A US38665406 A US 38665406A US 2006228814 A1 US2006228814 A1 US 2006228814A1
Authority
US
United States
Prior art keywords
metal
electrode
colloidal
kit
solution
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
US11/386,654
Inventor
Benoit Limoges
Laurent Authier
Murielle Dequaire
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Centre National de la Recherche Scientifique CNRS
Original Assignee
Centre National de la Recherche Scientifique CNRS
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Centre National de la Recherche Scientifique CNRS filed Critical Centre National de la Recherche Scientifique CNRS
Priority to US11/386,654 priority Critical patent/US20060228814A1/en
Publication of US20060228814A1 publication Critical patent/US20060228814A1/en
Abandoned legal-status Critical Current

Links

Images

Classifications

    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/58Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving labelled substances
    • G01N33/585Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving labelled substances with a particulate label, e.g. coloured latex
    • G01N33/587Nanoparticles
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2458/00Labels used in chemical analysis of biological material
    • G01N2458/30Electrochemically active labels

Definitions

  • markers which have been marketed fluorescent and luminescent markers, developed at the beginning of the 1970s, have many advantages: they are generally nontoxic and stable, and detection thereof is very sensitive. However, they require relatively sophisticated and expensive equipment, and the measurement is often affected by endogenous fluorescence associated with sample matrix effects.
  • Enzymatic markers which appeared at the same time as fluorescent markers, are probably today the most popular due to their notable catalytic properties, but also because of their ability to trigger, for certain substrates, colored reactions which permit the use of a very simple detector, such as a colorimeter, or even a manipulator's eye. Enzymatic markers are the basis for methods called ELISA (Enzyme-Linked ImmunoSorbant Assay). These too have their own disadvantages however. Certain substances present in the sample may inhibit the enzyme. In addition, they are relatively fragile and have a limited lifetime. Moreover, the background noise can be considerable.
  • Metal-based markers were introduced toward the end of the 1970s, with the aim, partly, of remedying certain of the abovementioned disadvantages.
  • Metal-based markers are distinguished according to their chemical nature, namely colloidal metal particles, metal ions, coordination complexes, organometallics or else metalloproteins.
  • various analytical techniques can be associated with them, such as time-resolved fluorescence, atomic absorption spectrophotometry or Fourier transform infrared, or else electrochemical techniques such as polarography or voltammetry.
  • electrochemical techniques Compared to spectrophotometric methods, electrochemical techniques have many advantages: the measurements can be made in very small volumes of liquid (less than a microliter), in medium which is possibly turbid (in the case of sera), with the possibility of offering a good sensitivity for inexpensive, possibly portable (small in size) equipment.
  • electrochemical techniques make it possible to detect organometallic markers or ionic metals down to nanomolar (10 ⁇ 9 M) concentrations, this often remains insufficient, however, compared to fluorescent markers which themselves can be detected down to picomolar (10 ⁇ 12 M) thresholds.
  • the electrochemical detection strategy developed in the present invention shows that it is possible to attain concentrations of a metallic marker of the order of 10 ⁇ 12 M.
  • the invention relates more precisely to a method for electrochemical detection of a colloidal metal particle used as a marker in an immunoassay.
  • the invention also relates to the quantitative or qualitative determination of compounds which may be haptens, antigens or antibodies, but also compounds such as DNA or RNA fragments.
  • the invention may be extended to all analytical methods involving a specific, affinity interaction between a ligand and a host molecule, and in which it is necessary to add a marker for substantially quantifying said interaction.
  • many formats of immunoassays, whether competitive or noncompetitive, or of methods of nucleic acid hybridization, preferably in heterogeneous phase, can be applied.
  • colloidal metal particles as a marker is not new. Specifically, they are used very commonly as a contrasting agent in electromicroscopy techniques, in particular in the form of gold colloids coupled to antibodies for the purpose, for example, of determining the distribution of an antigen at the surface of a cell (Beesley, Proceedings RMS; 1985, 20, 187-196).
  • colloidal metal particle as a marker in the context of an affinity assay is relatively uncommon. In this respect, the existence of a patent (U.S. Pat. No. 4,313,734) and of a publication (Leuvering et al., J.
  • electrochemical detection a method for immunoanalyzing or assaying DNA by hybridization, involving the electrochemical detection or quantification of a colloidal metal marker, does not, for the moment, appear to have been described.
  • the existence of an article concerning the direct detection of a gold colloid covered with antibodies and adsorbed to the surface of a carbon paste electrode can, however, be reported (Gonzalez-Garcia and Costa-Garcia, Bioelectrochem. Bioenerg. 1995, 38, 389-395).
  • application to an immunoassay although envisioned, was not demonstrated.
  • the inventors sought to verify whether or not it was possible to carry out an immunoassay as envisioned by the authors, i.e. an immunoassay taking place at the very surface of the electrode and for which, after immunoreaction, the colloidal gold marker which has reacted in the proximity of the surface of the electrode is directly detected.
  • an immunoassay as envisioned by the authors, i.e. an immunoassay taking place at the very surface of the electrode and for which, after immunoreaction, the colloidal gold marker which has reacted in the proximity of the surface of the electrode is directly detected.
  • the result of this experiment made it possible to conclude that it was not possible to detect the gold colloid in this way, probably because the latter is no longer in immediate contact with the surface of the electrode.
  • the present invention makes it possible to be free of this problem by virtue of an indirect detection of the colloidal metal marker, which by the same token allows the use of a solid phase which may be different from the surface of the electrode.
  • the present invention allows the detection or quantification of a biological substance coupled to a colloidal metal particle, by electrochemical detection, said colloidal metal particle being dissolved, and detected by electrochemistry after having been reprecipitated at the surface of the electrode.
  • the subject of the invention is therefore a method for detection or quantification of a biological substance coupled to a colloidal metal particle, by electrochemical detection, characterized in that it comprises a step of dissolving said colloidal metal particle.
  • the electrochemical immunoassay method developed in the present invention can not only be more sensitive than the current enzymatic immunoassay techniques, but also offer the possibility of determining and/or quantifying several compounds simultaneously if several colloidal metal markers which are different in nature are used.
  • electrochemical methods permit the simultaneous detection of several metals in the course of the same measurement.
  • colloidal metal markers offer the advantage of being much more stable than radioisotopic or enzymatic markers, and they permit simple labeling of many substances, at low cost, without any loss of activity of these substances.
  • the chemical treatment to dissolve the colloidal metal particle is carried out in an acidic medium containing an oxidant.
  • concentration of oxidant is chosen so as to be in sufficient excess to dissolve the highest concentrations of colloidal metal marker.
  • a solution of hydrobromic acid containing bromine (Br 2 ) or hypobromous acid (HBrO) or a mixture of the two as oxidant is preferred (for example: 10 ⁇ 4 M of Br 2 in 0.1 or 1 M HBr), in particular when dissolution of a gold colloid is desired.
  • a solution of hydrochloric acid (for example 0.1 M) containing a bromide salt (concentration ⁇ 0.1 M) and bromine may also be suitable.
  • an additional treatment may be necessary to remove the excess oxidizing reagent such as bromine.
  • an excess of phenol, aniline, hydrazine, oxine or one of their derivatives, or else preferably an excess of 3-phenoxyacetic acid may be added to the medium.
  • the latter is preferable since it is less toxic.
  • a concentration of 5 ⁇ 10 ⁇ 4 M is generally sufficient.
  • the bromine may also be removed by degassing.
  • a reagent capable of complexing the metal ion in order to promote detection thereof.
  • complexation can transform a nonelectroactive metal ion into a detectable electroactive compound.
  • the complexed metal ion because it has a more marked hydrophobic nature, can adsorb to the electrode and thus be more detected with more sensitively by adsorptive cathodic stripping voltammetry (van den Berg, Anal. Chim. Acta, 1991, 250, 265-276).
  • the metal After the metal has dissolved, it is reduced at the surface of the electrode, preferably by applying a very negative potential. The potential is then varied in order to reoxidize the metal, which then goes into solution.
  • the intensity of the voltammetric peak (surface) reflects the amount of metal deposited on the electrode, and therefore the amount of colloidal particles initially present in the solution. This therefore makes it possible to perform the assaying. When particles consisting of different metals are used, simultaneous detection is possible due to the distinct reoxidation potentials of the various metals.
  • the colloidal metal particles may consist of metal, such as gold, silver, copper, platinum, rhodium, palladium, iridium, nickel or iron colloids, or else of metal compounds, such as, for example, metal oxides or halides or chalcogenides, such as Ag 2 O, AgI, Bi 2 O 5 , Cd 3 P 2 , CdS, CdSe, CdTe, Co 2 O 3 , CrO 3 , Cu 2 S, HgI 2 , MnO 2 , PbS, PbO 2 , SnO 2 , TiO 2 , RuO 2 , ZnO, ZnS or ZnO 2 , or metal hydroxides.
  • metal oxides or halides or chalcogenides such as Ag 2 O, AgI, Bi 2 O 5 , Cd 3 P 2 , CdS, CdSe, CdTe, Co 2 O 3 , CrO 3 , Cu 2 S, HgI 2 , MnO 2 ,
  • any metal or metal compound which can be detected electrochemically can be envisioned, preferably transition metals (van den Berg, Anal. Chim. Acta, 1991, 250, 265-276). Practical requirements mean that preference is given to the use of metals or metal compounds which are only barely present, or not at all, in the assaying medium, and more particularly those which offer the best detection limits with respect to the electrochemical techniques used.
  • the invention has been demonstrated in particular for a gold colloid.
  • the metal-based colloidal particles can be obtained using one of the many methods described in the scientific literature (Hayat, Ed, Colloidal gold: principles, methods, and applications ; Academic Press: San Diego, Calif., 1991—Mackay and Texter, Eds, Electrochemistry in colloids and dispersions , VCH Publishers: New York, 1992—Murray et al., J. Am. Chem. Soc. 1993, 115, 8706-8715—Frens, Nat. Phys. Sci. 1973, 241, 20-22—U.S. Pat. No. 5,637,508—Weller, Angew. Chem. Int. Ed. Engl. 1993, 32, 41-43—Wang and Herron, J. Phys. Chem.
  • the particles may be between 1 and 200 nm in size, with a very low dispersion.
  • metal colloids between 5 and 100 nm are preferred. The use of a particle of considerable size is liable to improve the sensitivity of the assay.
  • the colloidal metal particle can be coupled to an antibody, a protein receptor, an antigen, a hapten, a protein, a peptide, an oligonucleotide or a nucleic acid fragment (in particular DNA or RNA).
  • the term “coupling” is intended to mean any method of chemical or physical attachment, direct or indirect, to the surface of the particle, such as a covalent bond or an adsorption via electrostatic interactions, hydrogen bridges, etc. Many coupling protocols have been described (Beesley, Proceedings RMS, 1985, 20, 187-196—Oliver, Methods in molecular biology, 1999, 115, 331-334).
  • the species then labeled with the metal particle is then used as a reagent which, in combination with immunochemical reagents based on antibodies, protein receptors, haptens, antigens, proteins, peptides, oligonucleotides, or DNA or RNA fragments, buffer solutions, other chemical reagents, and an electrode-based electrochemical detection system, will make it possible to assay a given substance.
  • FIG. 1 The principle of the invention is, by way of example, illustrated in FIG. 1 , in the case of a sandwich-type noncompetitive immunoassay ( FIG. 1A ), and also for a competitive immunoassay ( FIG. 1B ).
  • the compound to be determined (the analyte) is initially captured with a first ligand (in the present case an antibody; for a hybridization assay, this would be an oligonucleotide) immobilized on a solid phase.
  • a first ligand in the present case an antibody; for a hybridization assay, this would be an oligonucleotide
  • the solid phase for immobilizing the ligand may, for example, be the bottom of a microcuvette (in the case of FIG. 1 ), the surface of a microbead (optionally magnetic), the surface of a membrane or else the surface of the electrode.
  • a second ligand here an antibody labeled with a metal colloid is added in such a way that it reacts with the analyte previously extracted on the solid phase.
  • the solid phase thus constituted is then washed then treated with an appropriate volume of a solution of reagent able to dissolve the colloidal metal marker which has reacted with the solid phase.
  • the metal thus solubilized in the ionic state is detected and quantified using an electrode either immersed in the solution (in situ method— FIG. 1A ), or after transfer of the solution (ex situ method).
  • the electrochemical response can then be qualitatively or quantitatively linked to the substance to be assayed.
  • the method consists in bringing a sample containing the substance to be assayed into contact with a known amount of said substance labeled with a metal colloid, and a certain amount of ligand (antibody) immobilized on a solid phase and directed against this substance. After a given reaction time, the nature and the amount of metal colloid present in the fraction bound is then, after an optional washing step, determined as indicated above after dissolution and then electrochemical detection.
  • microbeads for example made of latex or else of ferromagnetic oxide
  • the microbeads can be concentrated, after the immunoreaction step, on a small surface, such as, for example, the surface of a filtering membrane (U.S. Pat. No. 4,853,335—Tu et al., Anal. Chem. 1993, 65, 3631-3665) or else the bottom of a conical tube, thus offering the possibility of dissolving the metal colloid in a smaller volume of liquid than that in which the immunoreaction took place.
  • a filtering membrane U.S. Pat. No. 4,853,335—Tu et al., Anal. Chem. 1993, 65, 3631-3665
  • carbon-based electrodes are preferred, and more particularly disk electrodes ( FIG. 2A ) and strip microelectrodes ( FIG. 2B ) obtained by screen-printing with a carbon-based ink.
  • These electrodes are in fact particularly well suited since they can be mass-produced at low cost, and can therefore optionally be for single use.
  • their geometric form and also their size can be readily modifiable.
  • other types of electrode such as electrodes made of glass carbon, graphite, composite materials containing carbon, carbon fibers, and/or carbon paste.
  • the surface of the electrodes can be treated electrochemically or chemically in order to improve the sensitivity of detection of the dissolved metal (Kalcher, Electroanalysis, 1990, 2, 419-433—Kalcher et al., Electroanalysis, 1995, 7, 5-22—Ugo and Moretto, Electroanalysis, 1995, 7, 1105-1113).
  • This may be, by way of example, modification of the surface of the electrode or of the composition of the ink, with a polymer capable of attracting metal ions via electrostatic interaction or complexation, or else electrochemical pretreatment of the surface of the electrode.
  • Depositing a mercury film may also prove to be advantageous for certain metal ions which are difficult to detect on a carbon electrode.
  • the screen-printing technique is preferable, although other methods of industrial production, such as rotogravure, inkjet printing, or optionally photolithography may be adapted.
  • microelectrodes preferably of strip microelectrodes, obtained by screen-printing is particularly advantageous since they offer the possibility of carrying out measurements in very small volumes (of the order of a few microliters) for analytical performances which, in terms of sensitivity and limit of detection of metal ion, are generally improved (Wong and Ewing, Anal. Chem. 1990, 62, 2697-2702—Wang et al., J. Electroanal. Chem., 1993, 361, 77-83—Wang and Armalis, Electroanalysis, 1995, 7, 958-961—Alames-Varela and Costa-Garcia, Electroanalysis, 1997, 9, 1262-1266).
  • microelectrodes makes it possible to obtain deposition of the metal which is more effective than with a macroelectrode.
  • macroelectrodes requires the solution to be agitated in order to ensure that a sufficient amount of metal deposits at the surface of the electrode.
  • the inventors have observed that the use of microelectrodes makes it possible to do without this agitation step. This may explain the gain in sensitivity observed, although other hypotheses, due to the very nature of the microelectrode (very small in size), may also be envisioned.
  • Various techniques of electrochemical analysis may be used to assay the dissolved metal ions. They are preferentially anodic stripping voltammetry (or polarography) with a potential scan which may be linear, cyclic, square-ware, normal pulse or differential pulse, or with a superimposed sinusoidal voltage, or else anodic stripping chronopotentiometry.
  • ion exchange voltammetry adsorptive cathodic stripping voltammetry (or polarography) with a scan which may be linear, cyclic, square-ware, normal pulse or differential pulse, or with a superimposed sinusoidal voltage, or else chronoamperometry, chronocoulometry or linear, cyclic, square-wave, normal pulse or differential pulse voltammetry (or polarography) or voltammetry (or polarography) with a superimposed sinusoidal voltage.
  • ion exchange voltammetry adsorptive cathodic stripping voltammetry (or polarography) with a scan which may be linear, cyclic, square-ware, normal pulse or differential pulse, or with a superimposed sinusoidal voltage
  • chronoamperometry chronocoulometry or linear, cyclic, square-wave, normal pulse or differential pulse voltammetry (or polarography) or voltammetry (or polarography) with a superimposed sinusoidal voltage.
  • this electrode In order to avoid contamination of the assaying medium with the metal or the electrolyte of the reference electrode, it is advantageous to isolate this electrode with an extension which consists, at its end, of a porous material, and which is filled with an electrolyte.
  • a reference electrode screen-printed using an ink based on silver and silver chloride may also be envisioned.
  • the invention also relates to a kit for assaying at least one biological compound.
  • this kit comprises at least one reagent labeled with a colloidal metal particle and at least one electrode.
  • the kit according to the invention may also contain at least one reagent for dissolving the colloidal metal particle and, optionally, a reagent for eliminating the excess oxidizing reagent.
  • the kit may also contain a reagent capable of complexing the metal ion, in order to promote detection thereof.
  • the kit may also contain instructions in order to enable the method according to the present invention to be carried out.
  • FIG. 1 Diagrammatic representation of the principle of the invention illustrated in the case (A) of a noncompetitive immunoassay and (B) a competitive immunoassay.
  • FIG. 2 Diagrammatic representation of a screen-printed disk electrode (A) and microstrip electrode (B).
  • FIG. 3 Calibration curves for ionic gold, obtained (1) with a strip microelectrode and (2) with a disk electrode.
  • FIG. 4 Diagrammatic representation of the measuring device used to detect the gold dissolved in a small volume of a drop of solution.
  • FIG. 5 Calibration curves for two colloids of gold covered with streptavidin.
  • FIG. 6 (A) log-log calibration curve for the IgG noncompetitive immunoassay. (B) anodic stripping voltammetry curves obtained for various concentrations of IgG. The curves are identified by letters in order to make them correspond to the concentrations indicated by the same letters on the IgG calibration curve.
  • FIG. 7 Log-log calibration curve for the ⁇ -feto-protein noncompetitive immunoassay.
  • the experiments are carried out at ambient temperature.
  • bovine serum albumin (BSA, fraction V), the biotin-amidocaproyl coupled to BSA (B-BSA, biotin content: 8-12 mol/mol of BSA), the streptavidin labeled with colloidal gold (S—Au) 20 nm in diameter, and also the streptavidin coupled to albumin onto which 10 nm colloidal gold particles are adsorbed (SA-Au) come from Sigma Chemical Co.
  • a reference electrode (Ag/AgBr, NaBr set ) extended via an extension containing a saturated solution of NaBr, and an auxiliary electrode are them immersed in the 40 ⁇ l of solution previously deposited onto the surface of the screen-printed carbon electrode, as shown by the diagram in FIG. 4 .
  • the linear anodic stripping voltammetry measurements are then carried out in the following way:
  • the measurement may also be the integral of the peak, which then corresponds to a coulomb quantity (Q p ).
  • the calibration curves are represented in FIG. 5 , on a logarithmic scale, for each of the streptavidins labeled with gold. Better sensitivity with the SA-Au (curve 1) than with the S—Au (curve 2) can be noted.
  • ovalbumin ovalbumin
  • IgG goat immunoglobulin G
  • Sigma Chemical Co The anti-goat IgG labeled with an 18 nm gold colloid, and also the unlabeled anti-goat IgG, are polyclonal antibodies from the Jackson Immunoresearch Laboratories.
  • microwell Once the microwell has been emptied and rinsed with 2 ⁇ 100 ⁇ l of PBS-OA-T 100 ⁇ l of PBS-OA-T are introduced. After 30 minutes, the liquid is replaced with 35 ⁇ l of a dilute solution of anti-IgG labeled with colloidal gold (45-fold dilution of the solution marketed, in PBS-OA-T), and then incubated for 3 hours. A final rinsing cycle is carried out, washing the microwell 3 times with 200 ⁇ l of PBS-OA-T, followed by 2 ⁇ 100 ⁇ l of PBS. The liquid is then carefully drawn off, and the gold colloid attached to the walls of the microwell is then dissolved and detected as indicated in example 1.
  • FIG. 6A Some examples of measurements obtained by linear anodic stripping voltammetry are given in FIG. 6A , while the corresponding goat-IgG calibration curve is represented in FIG. 6B . Each point represents the mean of 2 measurements and each measurement was obtained with a different electrode (single-use electrode). A concentration of approximately 3 ⁇ 10 ⁇ 12 M of IgG could be determined.
  • a solution of monoclonal anti- ⁇ -fetoprotein (mouse antibody) at 24 ⁇ g ml ⁇ 1 in a carbonate buffer (15 mM, pH 9.6) are pipetted into a microwell and allowed to incubate overnight at 4° C. After having emptied the microwell and rinsed it with 2 ⁇ 250 ⁇ l of PBS-OA-T buffer, 250 ⁇ l of this same buffer are then added and allowed to incubate for 40 min.
  • the solution is then drawn off, and 80 ⁇ l of a solution of ⁇ -fetoprotein at x ng.ml ⁇ 1 (0.05 ⁇ x ⁇ 20) diluted in a PBS buffer containing 0.1% of Tween 20 are then introduced and allowed to incubate for 2 hours. Once the microwell has been emptied and rinsed with 2 ⁇ 250 ⁇ l of PBS-OA-T, 250 ⁇ l of PBS-OA-T are introduced. After 30 minutes, the liquid is replaced with 80 ⁇ l of a dilute solution of polyclonal anti- ⁇ -fetoprotein (goat antibody) diluted to 5 ⁇ l ml ⁇ 1 in PBS-OA-T, and incubated for 1 hour.
  • the liquid is then carefully drawn off, then the gold colloid attached to the walls of the microwell is then dissolved and detected with strip microelectrodes in the following way: 50 ⁇ l of a solution of 0.1 mM Br 2 in 0.1 M HBr are added to the microwells for 30 min; then 40 ⁇ l are transferred into new microwells containing 10 ⁇ l of a solution of 3-phenoxypropionic acid at 2 ⁇ 10 ⁇ 3 M in 0.1 N HBr. Detection of the dissolved gold is then carried out as indicated in example 1.
  • the carbon-based ink used to produce the strip micro-electrodes is a commercial ink produced by Acheson Colloid (Minico® inks of the M3000-1RS series or Electrodag® inks such as 423 SS or PF 407A).
  • the ink is screen-printed onto a rigid or semi-rigid support, preferably made of semicrystalline polystyrene or high-impact polystyrene (plates possibly between 0.1 and 2 mm thick).
  • the fineness of the screen-printing mask obtained on a taut screen mounted on a frame, and also the nature and the mesh size of the screen, condition to a large extent the quality of the ink deposit and also its thickness.
  • ink thicknesses of between 5 and 50 ⁇ m could be obtained using screen-printing frames comprising 77 or 120 threads/cm.
  • the ink Once the ink has been screen-printed, it is left to dry in an oven at between 60 and 100° C. Next, a polystyrene-based isolating layer is deposited or screen-printed in such a way as to re-cover part of the carbon ink previously screen-printed ( FIG. 2 ). After drying, the electrode thus constituted is cut up transversely along its thickness so as to reveal on the section a strip of carbon of micrometric thickness (depending on the thickness of carbon ink initially screen-printed) and of millimetric length (depending on the length of the motif of the electrode initially selected) ( FIG. 2B ).

Abstract

The invention concerns a method for detecting or quantifying a biological substance coupled with a colloidal metal particle by electrochemical detection, characterized in that it comprises a step which consists in dissolving by chemical treatment of said colloidal metal particle, prior to detection.

Description

    CROSS-REFERENCE TO RELATED APPLICATIONS
  • This is a divisional of application Ser. No. 10/311,854, filed Jun. 5, 2003, now allowed, incorporated by reference herein in its entirety and relied upon, which is a 35 U.S.C. 371 national phase application of International Application No. PCT/FR01/02000, filed Jun. 25, 2001 and claims the priority of French Application No. 00/08145 filed Jun. 26, 2000.
  • The detection and quantification of biological substances using immunoassay methods or methods for assaying DNA fragments by nucleic acid hybridization are extremely important in many fields of clinical biology (medical and biological research, diagnosis, genetics, screening for illicit substances in trace amounts, etc.) or even in the environmental field (detection of contaminants such as pesticides or bacteria). These methods make it possible to satisfy the double criteria of selectivity and sensitivity. Among these methods, immunoanalysis with a marker, based on antigen/antibody affinity recognition, is particularly effective and has become widespread due to the development of a large range of nonradioactive markers such as enzymatic, fluorescent or chemiluminescent markers, generally coupled to spectroscopic detection. However, each marker has its own advantages and disadvantages. Specifically, an ideal marker should satisfy various requirements; it should:
    • 1) be detectable in a sensitive manner using analytical instruments which are inexpensive and easy to manipulate,
    • 2) allow the labeled molecule (tracer) to remain soluble and stable in the assaying media,
    • 3) allow simple and effective labeling at a reasonable cost,
    • 4) having a long lifetime,
    • 5) be of no risk to the individual handling it,
    • 6) produce a tracer having a reactivity close to the unlabeled molecule,
    • 7) produce a minimal background noise.
  • Among the markers which have been marketed, fluorescent and luminescent markers, developed at the beginning of the 1970s, have many advantages: they are generally nontoxic and stable, and detection thereof is very sensitive. However, they require relatively sophisticated and expensive equipment, and the measurement is often affected by endogenous fluorescence associated with sample matrix effects.
  • Enzymatic markers, which appeared at the same time as fluorescent markers, are probably today the most popular due to their notable catalytic properties, but also because of their ability to trigger, for certain substrates, colored reactions which permit the use of a very simple detector, such as a colorimeter, or even a manipulator's eye. Enzymatic markers are the basis for methods called ELISA (Enzyme-Linked ImmunoSorbant Assay). These too have their own disadvantages however. Certain substances present in the sample may inhibit the enzyme. In addition, they are relatively fragile and have a limited lifetime. Moreover, the background noise can be considerable.
  • Metal-based markers were introduced toward the end of the 1970s, with the aim, partly, of remedying certain of the abovementioned disadvantages. Metal-based markers are distinguished according to their chemical nature, namely colloidal metal particles, metal ions, coordination complexes, organometallics or else metalloproteins. Depending on their nature, various analytical techniques can be associated with them, such as time-resolved fluorescence, atomic absorption spectrophotometry or Fourier transform infrared, or else electrochemical techniques such as polarography or voltammetry.
  • Compared to spectrophotometric methods, electrochemical techniques have many advantages: the measurements can be made in very small volumes of liquid (less than a microliter), in medium which is possibly turbid (in the case of sera), with the possibility of offering a good sensitivity for inexpensive, possibly portable (small in size) equipment. Although electrochemical techniques make it possible to detect organometallic markers or ionic metals down to nanomolar (10−9 M) concentrations, this often remains insufficient, however, compared to fluorescent markers which themselves can be detected down to picomolar (10−12 M) thresholds. The electrochemical detection strategy developed in the present invention shows that it is possible to attain concentrations of a metallic marker of the order of 10−12 M.
  • The invention relates more precisely to a method for electrochemical detection of a colloidal metal particle used as a marker in an immunoassay. The invention also relates to the quantitative or qualitative determination of compounds which may be haptens, antigens or antibodies, but also compounds such as DNA or RNA fragments. In general, the invention may be extended to all analytical methods involving a specific, affinity interaction between a ligand and a host molecule, and in which it is necessary to add a marker for substantially quantifying said interaction. Furthermore, many formats of immunoassays, whether competitive or noncompetitive, or of methods of nucleic acid hybridization, preferably in heterogeneous phase, can be applied.
  • The use of colloidal metal particles as a marker is not new. Specifically, they are used very commonly as a contrasting agent in electromicroscopy techniques, in particular in the form of gold colloids coupled to antibodies for the purpose, for example, of determining the distribution of an antigen at the surface of a cell (Beesley, Proceedings RMS; 1985, 20, 187-196). On the other hand, the use of a colloidal metal particle as a marker in the context of an affinity assay is relatively uncommon. In this respect, the existence of a patent (U.S. Pat. No. 4,313,734) and of a publication (Leuvering et al., J. Immunoassay, 1980, 1, 71-91) relating the use of a marker based on colloidal gold or colloidal silver in the context of an immunoassay with detection by atomic absorption or colorimetry may be noted. Other quite similar patents also relate the use of gold colloid as markers in immunoassays with colorimetric detection (U.S. Pat. No. 4,853,335, EP0310872, EP0258963). A detection, also calorimetric, has recently been described for the analysis of DNA fragments by hybridization, via a colloidal gold marker (Storhoff et al., J. Am. Chem. Soc. 1998, 120, 1959-1964).
  • As regards electrochemical detection, a method for immunoanalyzing or assaying DNA by hybridization, involving the electrochemical detection or quantification of a colloidal metal marker, does not, for the moment, appear to have been described. The existence of an article concerning the direct detection of a gold colloid covered with antibodies and adsorbed to the surface of a carbon paste electrode can, however, be reported (Gonzalez-Garcia and Costa-Garcia, Bioelectrochem. Bioenerg. 1995, 38, 389-395). However, application to an immunoassay, although envisioned, was not demonstrated.
  • In order to test this hypothesis, the inventors sought to verify whether or not it was possible to carry out an immunoassay as envisioned by the authors, i.e. an immunoassay taking place at the very surface of the electrode and for which, after immunoreaction, the colloidal gold marker which has reacted in the proximity of the surface of the electrode is directly detected. The result of this experiment made it possible to conclude that it was not possible to detect the gold colloid in this way, probably because the latter is no longer in immediate contact with the surface of the electrode. The present invention makes it possible to be free of this problem by virtue of an indirect detection of the colloidal metal marker, which by the same token allows the use of a solid phase which may be different from the surface of the electrode.
  • Thus, the present invention allows the detection or quantification of a biological substance coupled to a colloidal metal particle, by electrochemical detection, said colloidal metal particle being dissolved, and detected by electrochemistry after having been reprecipitated at the surface of the electrode. This makes it possible to increase the local concentration and the sensitivity threshold. The subject of the invention is therefore a method for detection or quantification of a biological substance coupled to a colloidal metal particle, by electrochemical detection, characterized in that it comprises a step of dissolving said colloidal metal particle.
  • The electrochemical immunoassay method developed in the present invention can not only be more sensitive than the current enzymatic immunoassay techniques, but also offer the possibility of determining and/or quantifying several compounds simultaneously if several colloidal metal markers which are different in nature are used. Specifically, electrochemical methods permit the simultaneous detection of several metals in the course of the same measurement. In addition, colloidal metal markers offer the advantage of being much more stable than radioisotopic or enzymatic markers, and they permit simple labeling of many substances, at low cost, without any loss of activity of these substances.
  • The chemical treatment to dissolve the colloidal metal particle is carried out in an acidic medium containing an oxidant. The concentration of oxidant is chosen so as to be in sufficient excess to dissolve the highest concentrations of colloidal metal marker. A solution of hydrobromic acid containing bromine (Br2) or hypobromous acid (HBrO) or a mixture of the two as oxidant is preferred (for example: 10−4 M of Br2 in 0.1 or 1 M HBr), in particular when dissolution of a gold colloid is desired. A solution of hydrochloric acid (for example 0.1 M) containing a bromide salt (concentration ≧0.1 M) and bromine may also be suitable. Depending on the nature of the metal colloid to be dissolved, other acidic media for dissolution (H2SO4, HClO4, HF, etc.) and oxidizing reagents (I2, Cl2, HClO, HIO, H2O2, HNO3, CN, Cr2O4 , MnO4 , . . . ) may be envisioned.
  • After dissolution, an additional treatment may be necessary to remove the excess oxidizing reagent such as bromine. To do this, an excess of phenol, aniline, hydrazine, oxine or one of their derivatives, or else preferably an excess of 3-phenoxyacetic acid, may be added to the medium. The latter is preferable since it is less toxic. A concentration of 5×10−4 M is generally sufficient. The bromine may also be removed by degassing.
  • It may be advantageous to add in solution a reagent capable of complexing the metal ion in order to promote detection thereof. Indeed, complexation can transform a nonelectroactive metal ion into a detectable electroactive compound. In addition, the complexed metal ion, because it has a more marked hydrophobic nature, can adsorb to the electrode and thus be more detected with more sensitively by adsorptive cathodic stripping voltammetry (van den Berg, Anal. Chim. Acta, 1991, 250, 265-276).
  • After the metal has dissolved, it is reduced at the surface of the electrode, preferably by applying a very negative potential. The potential is then varied in order to reoxidize the metal, which then goes into solution. The intensity of the voltammetric peak (surface) reflects the amount of metal deposited on the electrode, and therefore the amount of colloidal particles initially present in the solution. This therefore makes it possible to perform the assaying. When particles consisting of different metals are used, simultaneous detection is possible due to the distinct reoxidation potentials of the various metals.
  • Thus, it is possible to deduce the presence and/or the amount of biological substance initially coupled to the colloidal particle, as a function of the presence and/or amount of metal electrodeposited at the surface of the electrode.
  • The colloidal metal particles may consist of metal, such as gold, silver, copper, platinum, rhodium, palladium, iridium, nickel or iron colloids, or else of metal compounds, such as, for example, metal oxides or halides or chalcogenides, such as Ag2O, AgI, Bi2O5, Cd3P2, CdS, CdSe, CdTe, Co2O3, CrO3, Cu2S, HgI2, MnO2, PbS, PbO2, SnO2, TiO2, RuO2, ZnO, ZnS or ZnO2, or metal hydroxides. In general, any metal or metal compound which can be detected electrochemically can be envisioned, preferably transition metals (van den Berg, Anal. Chim. Acta, 1991, 250, 265-276). Practical requirements mean that preference is given to the use of metals or metal compounds which are only barely present, or not at all, in the assaying medium, and more particularly those which offer the best detection limits with respect to the electrochemical techniques used. The invention has been demonstrated in particular for a gold colloid.
  • The metal-based colloidal particles can be obtained using one of the many methods described in the scientific literature (Hayat, Ed, Colloidal gold: principles, methods, and applications; Academic Press: San Diego, Calif., 1991—Mackay and Texter, Eds, Electrochemistry in colloids and dispersions, VCH Publishers: New York, 1992—Murray et al., J. Am. Chem. Soc. 1993, 115, 8706-8715—Frens, Nat. Phys. Sci. 1973, 241, 20-22—U.S. Pat. No. 5,637,508—Weller, Angew. Chem. Int. Ed. Engl. 1993, 32, 41-43—Wang and Herron, J. Phys. Chem. 1991, 95, 525-532). Depending on the method of production, the particles may be between 1 and 200 nm in size, with a very low dispersion. In the present invention, metal colloids between 5 and 100 nm are preferred. The use of a particle of considerable size is liable to improve the sensitivity of the assay.
  • Depending on the format and the type of assay, the colloidal metal particle can be coupled to an antibody, a protein receptor, an antigen, a hapten, a protein, a peptide, an oligonucleotide or a nucleic acid fragment (in particular DNA or RNA). The term “coupling” is intended to mean any method of chemical or physical attachment, direct or indirect, to the surface of the particle, such as a covalent bond or an adsorption via electrostatic interactions, hydrogen bridges, etc. Many coupling protocols have been described (Beesley, Proceedings RMS, 1985, 20, 187-196—Oliver, Methods in molecular biology, 1999, 115, 331-334). The species then labeled with the metal particle is then used as a reagent which, in combination with immunochemical reagents based on antibodies, protein receptors, haptens, antigens, proteins, peptides, oligonucleotides, or DNA or RNA fragments, buffer solutions, other chemical reagents, and an electrode-based electrochemical detection system, will make it possible to assay a given substance.
  • The principle of the invention is, by way of example, illustrated in FIG. 1, in the case of a sandwich-type noncompetitive immunoassay (FIG. 1A), and also for a competitive immunoassay (FIG. 1B).
  • For the first approach (FIG. 1A), the compound to be determined (the analyte) is initially captured with a first ligand (in the present case an antibody; for a hybridization assay, this would be an oligonucleotide) immobilized on a solid phase. The solid phase for immobilizing the ligand may, for example, be the bottom of a microcuvette (in the case of FIG. 1), the surface of a microbead (optionally magnetic), the surface of a membrane or else the surface of the electrode. After a given incubation period, optionally followed by a washing step, a second ligand (here an antibody) labeled with a metal colloid is added in such a way that it reacts with the analyte previously extracted on the solid phase. The solid phase thus constituted is then washed then treated with an appropriate volume of a solution of reagent able to dissolve the colloidal metal marker which has reacted with the solid phase. Then, the metal thus solubilized in the ionic state is detected and quantified using an electrode either immersed in the solution (in situ method—FIG. 1A), or after transfer of the solution (ex situ method). The electrochemical response can then be qualitatively or quantitatively linked to the substance to be assayed.
  • In the case of the second approach (FIG. 1B), the method consists in bringing a sample containing the substance to be assayed into contact with a known amount of said substance labeled with a metal colloid, and a certain amount of ligand (antibody) immobilized on a solid phase and directed against this substance. After a given reaction time, the nature and the amount of metal colloid present in the fraction bound is then, after an optional washing step, determined as indicated above after dissolution and then electrochemical detection.
  • The use of a solid phase consisting of microbeads, for example made of latex or else of ferromagnetic oxide, may be particularly advantageous for improving the sensitivity and lowering the limit of detection. Specifically, the microbeads can be concentrated, after the immunoreaction step, on a small surface, such as, for example, the surface of a filtering membrane (U.S. Pat. No. 4,853,335—Tu et al., Anal. Chem. 1993, 65, 3631-3665) or else the bottom of a conical tube, thus offering the possibility of dissolving the metal colloid in a smaller volume of liquid than that in which the immunoreaction took place.
  • Methods based on agglutination and/or precipitation in homogeneous phase of the colloidal metal marker in the course of an immunoreaction or oligonucleotide hybridization can also be envisioned (U.S. Pat. No. 5,851,777). In this case, the aggregates formed are isolated and then dissolved and detected as previously.
  • As regards the nature of the electrodes, carbon-based electrodes are preferred, and more particularly disk electrodes (FIG. 2A) and strip microelectrodes (FIG. 2B) obtained by screen-printing with a carbon-based ink. These electrodes are in fact particularly well suited since they can be mass-produced at low cost, and can therefore optionally be for single use. In addition, their geometric form and also their size can be readily modifiable. However, other types of electrode may be used, such as electrodes made of glass carbon, graphite, composite materials containing carbon, carbon fibers, and/or carbon paste. In addition, the surface of the electrodes can be treated electrochemically or chemically in order to improve the sensitivity of detection of the dissolved metal (Kalcher, Electroanalysis, 1990, 2, 419-433—Kalcher et al., Electroanalysis, 1995, 7, 5-22—Ugo and Moretto, Electroanalysis, 1995, 7, 1105-1113). This may be, by way of example, modification of the surface of the electrode or of the composition of the ink, with a polymer capable of attracting metal ions via electrostatic interaction or complexation, or else electrochemical pretreatment of the surface of the electrode. Depositing a mercury film may also prove to be advantageous for certain metal ions which are difficult to detect on a carbon electrode. As regards the method of producing the electrodes, the screen-printing technique is preferable, although other methods of industrial production, such as rotogravure, inkjet printing, or optionally photolithography may be adapted.
  • According to the characteristics of the invention, the use of microelectrodes, preferably of strip microelectrodes, obtained by screen-printing is particularly advantageous since they offer the possibility of carrying out measurements in very small volumes (of the order of a few microliters) for analytical performances which, in terms of sensitivity and limit of detection of metal ion, are generally improved (Wong and Ewing, Anal. Chem. 1990, 62, 2697-2702—Wang et al., J. Electroanal. Chem., 1993, 361, 77-83—Wang and Armalis, Electroanalysis, 1995, 7, 958-961—Alames-Varela and Costa-Garcia, Electroanalysis, 1997, 9, 1262-1266).
  • FIG. 3, which compares the calibration curves (current densities) of AuBr4 in 0.1 M HBr, obtained on a screen-printed strip microelectrode with a surface area S=1.7×10−4 cm2 (curve 1) and on a screen-printed disk macroelectrode with a surface area S=0.0962 cm2 (curve 2), confirms better sensitivity in the case of the strip microelectrode. These curves were obtained by linear anodic stripping voltammetry in the following way: (I) electrodeposition of gold at a constant potential of E=−0.3 V for 300 s, (ii) then linear potential scan from 0.2 V up to 1.1 V at a rate of 50 mVs−1. The peak current (ip) appears around 1.0 V, linked to oxidation of the gold, and is taken as the analytical response.
  • It in fact appears that the use of microelectrodes makes it possible to obtain deposition of the metal which is more effective than with a macroelectrode. Specifically, the use of macroelectrodes requires the solution to be agitated in order to ensure that a sufficient amount of metal deposits at the surface of the electrode. Surprisingly, the inventors have observed that the use of microelectrodes makes it possible to do without this agitation step. This may explain the gain in sensitivity observed, although other hypotheses, due to the very nature of the microelectrode (very small in size), may also be envisioned.
  • Various techniques of electrochemical analysis may be used to assay the dissolved metal ions. They are preferentially anodic stripping voltammetry (or polarography) with a potential scan which may be linear, cyclic, square-ware, normal pulse or differential pulse, or with a superimposed sinusoidal voltage, or else anodic stripping chronopotentiometry. However, other techniques may be used, such as ion exchange voltammetry, adsorptive cathodic stripping voltammetry (or polarography) with a scan which may be linear, cyclic, square-ware, normal pulse or differential pulse, or with a superimposed sinusoidal voltage, or else chronoamperometry, chronocoulometry or linear, cyclic, square-wave, normal pulse or differential pulse voltammetry (or polarography) or voltammetry (or polarography) with a superimposed sinusoidal voltage. These techniques require a possibly two-electrode or even three-electrode assembly, i.e. an assembly comprising the abovementioned measuring electrode, a reference electrode and, optionally, an auxiliary electrode. In order to avoid contamination of the assaying medium with the metal or the electrolyte of the reference electrode, it is advantageous to isolate this electrode with an extension which consists, at its end, of a porous material, and which is filled with an electrolyte. A reference electrode screen-printed using an ink based on silver and silver chloride may also be envisioned. Here again, it may be useful to isolate this electrode via an electrolyte bridge, such as, for example, an ionic conducting gel or an ionic conducting polymer, in order to avoid interference from the silver ions during a measurement.
  • The invention also relates to a kit for assaying at least one biological compound. According to the characteristics of the invention, this kit comprises at least one reagent labeled with a colloidal metal particle and at least one electrode. The kit according to the invention may also contain at least one reagent for dissolving the colloidal metal particle and, optionally, a reagent for eliminating the excess oxidizing reagent. The kit may also contain a reagent capable of complexing the metal ion, in order to promote detection thereof. Finally, the kit may also contain instructions in order to enable the method according to the present invention to be carried out.
  • The following examples illustrate the characteristics of the invention, but should not be considered to limit the invention.
  • DESCRIPTION OF THE FIGURES
  • FIG. 1. Diagrammatic representation of the principle of the invention illustrated in the case (A) of a noncompetitive immunoassay and (B) a competitive immunoassay.
  • FIG. 2. Diagrammatic representation of a screen-printed disk electrode (A) and microstrip electrode (B).
  • FIG. 3. Calibration curves for ionic gold, obtained (1) with a strip microelectrode and (2) with a disk electrode.
  • FIG. 4. Diagrammatic representation of the measuring device used to detect the gold dissolved in a small volume of a drop of solution.
  • FIG. 5. Calibration curves for two colloids of gold covered with streptavidin.
  • FIG. 6. (A) log-log calibration curve for the IgG noncompetitive immunoassay. (B) anodic stripping voltammetry curves obtained for various concentrations of IgG. The curves are identified by letters in order to make them correspond to the concentrations indicated by the same letters on the IgG calibration curve.
  • FIG. 7. Log-log calibration curve for the α-feto-protein noncompetitive immunoassay.
  • EXAMPLES Example 1 Detection of Streptavidin Labeled with a Gold Colloid after Specific Attachment to the Bottom of a Microwell
  • The experiments are carried out at ambient temperature.
  • The bovine serum albumin (BSA, fraction V), the biotin-amidocaproyl coupled to BSA (B-BSA, biotin content: 8-12 mol/mol of BSA), the streptavidin labeled with colloidal gold (S—Au) 20 nm in diameter, and also the streptavidin coupled to albumin onto which 10 nm colloidal gold particles are adsorbed (SA-Au) come from Sigma Chemical Co.
  • 100 μl of B-BSA at 10 μg ml−1 in a bicarbonate buffer (15 mM Na2CO3; pH 9.6) are pipetted at the bottom of a polystyrene microwell (Nunc) an allowed to incubate for 2 hours. After having emptied the microwell and rinsed it with 110 μl of phosphate buffer (PBS: 4.3 mM NaH2PO4, 15.1 mM Na2HPO4 and 50 mM NaCl; pH 7.4), 100 μl of PBS containing 0.1% of BSA (PBS-BSA) are added and allowed to incubate for 2 hours. The microwell is then emptied and rinsed 3 times with 110 μl of pure water. Next, 35 μl of a solution of S—Au or SA-Au at x μg.ml−1 (0.003<x<3) in a PBS-BSA buffer containing 0.05% of Tween 20 (PBS-BSA-T) are then introduced into the microwell and allowed to react for 3 hours. Once emptied, the microwell is thoroughly washed with 3×110 μl of PBS-BSA-T, and then with 2×110 μl of PBS. The gold colloid attached to the walls of the microwell is then dissolved by introducing 40 μl of a solution of Br2 at a concentration of 10−4 M in 1 M HBr. After 5 minutes, a volume of 35 μl is removed from the microwell and transferred onto the surface of a screen-printed carbon disk electrode (S=0.0962 cm2, electrode prepared according to the method described in the ref.: Bagel et al., Anal. Chem. 1997, 69, 4688-4694), to which are added 5 μl of a fresh solution of 3-phenoxypropionic acid at 4×10−3 M in 1 M HBr. A reference electrode (Ag/AgBr, NaBrset) extended via an extension containing a saturated solution of NaBr, and an auxiliary electrode are them immersed in the 40 μl of solution previously deposited onto the surface of the screen-printed carbon electrode, as shown by the diagram in FIG. 4. The linear anodic stripping voltammetry measurements are then carried out in the following way:
    • 1) electrodeposition of the gold at a constant potential of E=−0.3 V for 300 s,
    • 2) then a linear potential scan from 0.2 V up to 1.1 V at a rate of 50 mVs−1.
  • The peak current (ip) which appears around 1.0 V, linked to oxidation of the gold, is taken as the analytical response. The measurement may also be the integral of the peak, which then corresponds to a coulomb quantity (Qp). The calibration curves are represented in FIG. 5, on a logarithmic scale, for each of the streptavidins labeled with gold. Better sensitivity with the SA-Au (curve 1) than with the S—Au (curve 2) can be noted.
  • Example 2 “Sandwich” Immunoassay for an Immunoglobulin
  • The ovalbumin (OA, grade III) and the goat immunoglobulin G (IgG) is marketed by Sigma Chemical Co. The anti-goat IgG labeled with an 18 nm gold colloid, and also the unlabeled anti-goat IgG, are polyclonal antibodies from the Jackson Immunoresearch Laboratories.
  • 60 μl of a solution of anti-IgG at 24 μg ml−1 in a PBS buffer are pipetted into a microwell and allowed to incubate for 1 hour. After having emptied the microwell and rinsed it with 2×100 μl of PBS buffer containing 0.5% of ovalbumin and 0.1% of Tween 20 (PBS-OA-T), 100 μl of this same buffer are then added and allowed to incubate for 1 hour. The solution is then drawn off, and 35 μl of a solution of goat IgG at x ng.ml−1 (0.5<x<1 000) diluted in a PBS buffer containing 0.1% of Tween 20 are then introduced and allowed to incubate for 40 minutes. Once the microwell has been emptied and rinsed with 2×100 μl of PBS-OA-T 100 μl of PBS-OA-T are introduced. After 30 minutes, the liquid is replaced with 35 μl of a dilute solution of anti-IgG labeled with colloidal gold (45-fold dilution of the solution marketed, in PBS-OA-T), and then incubated for 3 hours. A final rinsing cycle is carried out, washing the microwell 3 times with 200 μl of PBS-OA-T, followed by 2×100 μl of PBS. The liquid is then carefully drawn off, and the gold colloid attached to the walls of the microwell is then dissolved and detected as indicated in example 1.
  • Some examples of measurements obtained by linear anodic stripping voltammetry are given in FIG. 6A, while the corresponding goat-IgG calibration curve is represented in FIG. 6B. Each point represents the mean of 2 measurements and each measurement was obtained with a different electrode (single-use electrode). A concentration of approximately 3×10−12 M of IgG could be determined.
  • Example 3 Noncompetitive Immunoassay for Human α-feto-protein
  • 80 μl of a solution of monoclonal anti-α-fetoprotein (mouse antibody) at 24 μg ml−1 in a carbonate buffer (15 mM, pH 9.6) are pipetted into a microwell and allowed to incubate overnight at 4° C. After having emptied the microwell and rinsed it with 2×250 μl of PBS-OA-T buffer, 250 μl of this same buffer are then added and allowed to incubate for 40 min. The solution is then drawn off, and 80 μl of a solution of α-fetoprotein at x ng.ml−1 (0.05<x<20) diluted in a PBS buffer containing 0.1% of Tween 20 are then introduced and allowed to incubate for 2 hours. Once the microwell has been emptied and rinsed with 2×250 μl of PBS-OA-T, 250 μl of PBS-OA-T are introduced. After 30 minutes, the liquid is replaced with 80 μl of a dilute solution of polyclonal anti-α-fetoprotein (goat antibody) diluted to 5 μl ml−1 in PBS-OA-T, and incubated for 1 hour. Then, after rinsing with 2×250 μl of PBS-OA-T buffer, 50 μl of a solution of anti-goat IgG labeled with colloidal gold (45-fold dilution of the solution marketed, in PBS-OA-T) [lacuna], and then incubated for 1 h 30 min. A final rinsing cycle is carried out, washing the microwell 3 times with 250 μl of PBS-OA-T, followed by 2×250 μl of PBS-T, then 2×250 μl of PBS. The liquid is then carefully drawn off, then the gold colloid attached to the walls of the microwell is then dissolved and detected with strip microelectrodes in the following way: 50 μl of a solution of 0.1 mM Br2 in 0.1 M HBr are added to the microwells for 30 min; then 40 μl are transferred into new microwells containing 10 μl of a solution of 3-phenoxypropionic acid at 2×10−3 M in 0.1 N HBr. Detection of the dissolved gold is then carried out as indicated in example 1.
  • Production of Screen-Printed Strip Microelectrodes:
  • The carbon-based ink used to produce the strip micro-electrodes is a commercial ink produced by Acheson Colloid (Minico® inks of the M3000-1RS series or Electrodag® inks such as 423 SS or PF 407A). The ink is screen-printed onto a rigid or semi-rigid support, preferably made of semicrystalline polystyrene or high-impact polystyrene (plates possibly between 0.1 and 2 mm thick). The fineness of the screen-printing mask obtained on a taut screen mounted on a frame, and also the nature and the mesh size of the screen, condition to a large extent the quality of the ink deposit and also its thickness. In the present invention, ink thicknesses of between 5 and 50 μm could be obtained using screen-printing frames comprising 77 or 120 threads/cm.
  • Once the ink has been screen-printed, it is left to dry in an oven at between 60 and 100° C. Next, a polystyrene-based isolating layer is deposited or screen-printed in such a way as to re-cover part of the carbon ink previously screen-printed (FIG. 2). After drying, the electrode thus constituted is cut up transversely along its thickness so as to reveal on the section a strip of carbon of micrometric thickness (depending on the thickness of carbon ink initially screen-printed) and of millimetric length (depending on the length of the motif of the electrode initially selected) (FIG. 2B).

Claims (10)

1. A diagnostic kit, comprising at least one reagent labeled with colloidal metal particles and at least one electrode, and also an agent for chemically dissolving said colloidal metal particles.
2. The kit according to claim 1, further comprising a reagent capable of complexing the metal ions.
3. The kit according to claim 1, further including instructions for the electrochemical detection or quantification of a biological substance using said kit.
4. The kit according to claim 1, wherein the agent for dissolving said colloidal metal particles is an acidic medium containing an oxidant.
5. The kit according to claim 2, wherein the reagent capable of complexing the metal ions is in solution.
6. The kit as claimed in claim 1, wherein the colloidal particles are selected from the group consisting of particles comprising metal and metal compounds.
7. The kit as claimed in claim 6, wherein the colloidal particles are gold.
8. The kit as claimed in claim 1, wherein the colloidal particles are each between 1 and 200 nm in size.
9. The kit as claimed in claim 4, wherein the acidic medium containing an oxidant is a solution of hydrobromic acid containing bromine, hypobromous acid or a mixture of these two compounds.
10. The kit as claimed in claim 1, wherein the electrode is a screen-printed electrode.
US11/386,654 2000-06-26 2006-03-23 Electrochemical immunoassays using colloidal metal markers Abandoned US20060228814A1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
US11/386,654 US20060228814A1 (en) 2000-06-26 2006-03-23 Electrochemical immunoassays using colloidal metal markers

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
FR0008145A FR2810739B1 (en) 2000-06-26 2000-06-26 ELECTROCHEMICAL IMMUNODOSIS USING COLLOIDAL METAL MARKERS
FR0008145 2000-06-26
PCT/FR2001/002000 WO2002001178A2 (en) 2000-06-26 2001-06-25 Electrochemical immunoassays using colloidal metal markers
US10/311,854 US7045364B2 (en) 2000-06-26 2001-06-25 Electrochemical immunoassays using colloidal metal markers
US11/386,654 US20060228814A1 (en) 2000-06-26 2006-03-23 Electrochemical immunoassays using colloidal metal markers

Related Parent Applications (2)

Application Number Title Priority Date Filing Date
US10/311,854 Division US7045364B2 (en) 2000-06-26 2001-06-25 Electrochemical immunoassays using colloidal metal markers
PCT/FR2001/002000 Division WO2002001178A2 (en) 2000-06-26 2001-06-25 Electrochemical immunoassays using colloidal metal markers

Publications (1)

Publication Number Publication Date
US20060228814A1 true US20060228814A1 (en) 2006-10-12

Family

ID=8851658

Family Applications (2)

Application Number Title Priority Date Filing Date
US10/311,854 Expired - Fee Related US7045364B2 (en) 2000-06-26 2001-06-25 Electrochemical immunoassays using colloidal metal markers
US11/386,654 Abandoned US20060228814A1 (en) 2000-06-26 2006-03-23 Electrochemical immunoassays using colloidal metal markers

Family Applications Before (1)

Application Number Title Priority Date Filing Date
US10/311,854 Expired - Fee Related US7045364B2 (en) 2000-06-26 2001-06-25 Electrochemical immunoassays using colloidal metal markers

Country Status (9)

Country Link
US (2) US7045364B2 (en)
EP (1) EP1303759B1 (en)
JP (1) JP4768202B2 (en)
AT (1) ATE306670T1 (en)
AU (1) AU2001269256A1 (en)
CA (1) CA2413929C (en)
DE (1) DE60114016T2 (en)
FR (1) FR2810739B1 (en)
WO (1) WO2002001178A2 (en)

Cited By (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2462062A (en) * 2008-07-14 2010-01-27 Sec Dep For Innovation Univers Electrochemical assay
US20100320092A1 (en) * 2007-11-26 2010-12-23 The Secretary Of State For Innovation Universities And Skills Of Her Majesty's Britanni Electrochemical Detection of a Metal - Labelled Analyte
US20110171735A1 (en) * 2008-07-10 2011-07-14 Robert Andrew Porter Apparatus and Methods for Effecting Chemical Assays
EP2796876A1 (en) * 2013-04-25 2014-10-29 Hasenkam ApS Strip for monitoring analyte concentrations
US8927299B2 (en) 2008-07-10 2015-01-06 The Secretary Of State For Innovation, Universities And Skills Of Her Majesty's Britannic Government Sample carrier for effecting chemical assays
US10232365B2 (en) 2012-09-28 2019-03-19 Agplus Diagnostics Ltd Test device and sample carrier
WO2020000959A1 (en) * 2018-06-29 2020-01-02 北京华科泰生物技术股份有限公司 Electrochemical detection method based on marking with markers
EP3960291A1 (en) * 2020-08-28 2022-03-02 ETH Zurich In-situ controlled dissolution of metals using electrochemistry

Families Citing this family (40)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR100893525B1 (en) * 2002-12-09 2009-04-17 삼성전자주식회사 A method of detecting a target molecule using a microwire formed by a gold colloidal particles
EP1740951B1 (en) * 2004-04-29 2008-03-05 Marc Ramael Method and kit for detecting components in a sample
CA2569620C (en) * 2004-06-07 2014-05-13 Inverness Medical Switzerland Gmbh Method for determining the presence or amount of a silver-labelled species
GB0412659D0 (en) * 2004-06-07 2004-07-07 Inverness Medical Switzerland Method
EP1808407B1 (en) 2004-09-30 2014-12-31 Japan Science and Technology Agency Method of patterning self-organizing material, patterned substrate of self-organizing material and method of producing the same, and phosomask using patterned substrate of self-organizing material
US20090159458A1 (en) * 2006-04-07 2009-06-25 Bio Device Technology Ltd. Method for Determination of Test Substance
US8026108B1 (en) * 2006-10-19 2011-09-27 The University Of Central Florida Research Foundation, Inc. Detection of biotargets using bioreceptor functionalized nanoparticles
US7776605B2 (en) * 2006-10-26 2010-08-17 Abbott Laboratories Assay for cardiac troponin autoantibodies
US20080305512A1 (en) * 2006-10-26 2008-12-11 Mattingly Phillip G Assay for cardiac troponin autoantibodies
WO2008051762A2 (en) * 2006-10-26 2008-05-02 Abbott Laboratories Immunoassay of analytes in samples containing endogenous anti-analyte antibodies
JP5319549B2 (en) 2006-12-29 2013-10-16 アボット・ラボラトリーズ Non-denaturing cell lysis reagent for in-solution capture immunoassay
US7914999B2 (en) 2006-12-29 2011-03-29 Abbott Laboratories Non-denaturing lysis reagent
MY173855A (en) * 2007-03-21 2020-02-25 Univ Putra Malaysia Amperometric biosensor for histamine determination
JP4915740B2 (en) * 2007-07-20 2012-04-11 国立大学法人北陸先端科学技術大学院大学 Silver ion measurement method and test substance measurement method
JP4915741B2 (en) * 2007-07-31 2012-04-11 国立大学法人北陸先端科学技術大学院大学 Test substance measurement method
JP5473382B2 (en) * 2008-04-17 2014-04-16 キヤノン株式会社 Immunoassay method
JP5327739B2 (en) * 2008-05-12 2013-10-30 国立大学法人北陸先端科学技術大学院大学 Test substance measurement method
US7842637B2 (en) * 2008-05-23 2010-11-30 Lumimove, Inc. Electroactivated film with polymer gel electrolyte
US8383337B2 (en) * 2008-07-18 2013-02-26 General Electric Company Methods using metal oxide particles for analyte detection
JP2010107502A (en) * 2008-09-30 2010-05-13 Sekisui Chem Co Ltd Quantitative analyzing method and detecting cartridge
JP5099787B2 (en) * 2009-09-24 2012-12-19 積水化学工業株式会社 Quantitative analysis method
US8835120B2 (en) * 2009-12-02 2014-09-16 Abbott Laboratories Assay for cardiac troponin-T (cTnT)
US8652788B2 (en) 2009-12-02 2014-02-18 Abbott Laboratories Assay for diagnosis of cardiac myocyte damage
US8183002B2 (en) 2009-12-03 2012-05-22 Abbott Laboratories Autoantibody enhanced immunoassays and kits
US20110136141A1 (en) 2009-12-03 2011-06-09 Abbott Laboratories Peptide reagents and method for inhibiting autoantibody antigen binding
US9103762B2 (en) 2010-10-28 2015-08-11 Eth Zurich Method for electrical detection of biomolecules by metal dissolution and Assay kit therefore
JP5455878B2 (en) * 2010-11-30 2014-03-26 シスメックス株式会社 Electrochemical detection method for test substances
CN105388287A (en) 2011-03-11 2016-03-09 内布拉斯加大学董事委员会 Biomarker for coronary artery disease
JP5571705B2 (en) * 2012-01-12 2014-08-13 株式会社Lsiメディエンス Electrical analysis method
IN2012DE00264A (en) * 2012-01-31 2015-07-10 Council Scient Ind Res
JP6486065B2 (en) * 2014-10-28 2019-03-20 シスメックス株式会社 Detection method of test substance
EP3292395A4 (en) 2015-04-08 2019-01-02 Board of Regents, The University of Texas System Methods and systems for the detection of analytes
WO2016167724A1 (en) * 2015-04-13 2016-10-20 Agency For Science, Technology And Research Device for electrochemical immunoassay and method of fabricating the same
US20170179199A1 (en) * 2015-12-18 2017-06-22 Dpix, Llc Method of screen printing in manufacturing an image sensor device
CN106324058B (en) * 2016-08-09 2018-09-14 济南大学 A kind of preparation method and application of highly sensitive no enzyme electrochemical immunosensor
CN109142745B (en) * 2018-07-27 2021-08-20 济南大学 Preparation method and application of photoelectrochemical immunosensor based on stannic oxide/cadmium carbonate/cadmium sulfide
CN111751416A (en) * 2020-07-03 2020-10-09 福建中医药大学 Novel periplaneta americana polypeptide rapid detection method
JPWO2022185696A1 (en) * 2021-03-02 2022-09-09
GB2622185A (en) 2022-05-25 2024-03-13 John William Dilleen Electrochemical energy diagnostics device for sample analysis
KR102543112B1 (en) * 2023-04-12 2023-06-13 주식회사 브레디스헬스케어 Method for detecting particles of a target substance contained in a small amount in a fluid sample

Citations (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4313734A (en) * 1978-07-13 1982-02-02 Akzona Incorporated Metal sol particle immunoassay
US4373050A (en) * 1966-06-01 1983-02-08 Amchem Products, Inc. Process and composition for coating metals
US4444879A (en) * 1981-01-29 1984-04-24 Science Research Center, Inc. Immunoassay with article having support film and immunological counterpart of analyte
US4703017A (en) * 1984-02-14 1987-10-27 Becton Dickinson And Company Solid phase assay with visual readout
US4853335A (en) * 1987-09-28 1989-08-01 Olsen Duane A Colloidal gold particle concentration immunoassay
US5292423A (en) * 1991-04-09 1994-03-08 New Mexico State University Technology Transfer Corp. Method and apparatus for trace metal testing
US5304359A (en) * 1992-03-03 1994-04-19 Bhp Minerals International Inc. Dissolution of platinum group metals from materials containing said metals
US5591581A (en) * 1986-04-30 1997-01-07 Igen, Inc. Electrochemiluminescent rhenium moieties and methods for their use
US5637508A (en) * 1993-03-26 1997-06-10 Geo-Centers, Inc. Biomolecules bound to polymer or copolymer coated catalytic inorganic particles, immunoassays using the same and kits containing the same
US5650333A (en) * 1990-12-24 1997-07-22 Nycomed Pharma As Immunoassay method and kit using superaggregated complex
US5851777A (en) * 1996-02-05 1998-12-22 Dade Behring Inc. Homogeneous sol-sol assay
US6713308B1 (en) * 1999-05-05 2004-03-30 Fang Lu System for electrochemical quantitative analysis of analytes within a solid phase

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU7385387A (en) 1986-06-09 1987-12-10 Ortho Diagnostic Systems Inc. Immunoassay using detection of colloidal gold
US4859612A (en) * 1987-10-07 1989-08-22 Hygeia Sciences, Inc. Metal sol capture immunoassay procedure, kit for use therewith and captured metal containing composite
US6319670B1 (en) * 1995-05-09 2001-11-20 Meso Scale Technology Llp Methods and apparatus for improved luminescence assays using microparticles
ES2102970B1 (en) * 1995-07-18 1998-04-01 Univ Oviedo ANALYTICAL ELECTRO-IMMUNO ASSAYS AND BIOLOGICAL RECOGNITION ELECTRO-ASSAYS.
JP3441376B2 (en) * 1998-08-18 2003-09-02 京セラケミカル株式会社 Analysis method and kit

Patent Citations (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4373050A (en) * 1966-06-01 1983-02-08 Amchem Products, Inc. Process and composition for coating metals
US4313734A (en) * 1978-07-13 1982-02-02 Akzona Incorporated Metal sol particle immunoassay
US4444879A (en) * 1981-01-29 1984-04-24 Science Research Center, Inc. Immunoassay with article having support film and immunological counterpart of analyte
US4703017A (en) * 1984-02-14 1987-10-27 Becton Dickinson And Company Solid phase assay with visual readout
US4703017C1 (en) * 1984-02-14 2001-12-04 Becton Dickinson Co Solid phase assay with visual readout
US5591581A (en) * 1986-04-30 1997-01-07 Igen, Inc. Electrochemiluminescent rhenium moieties and methods for their use
US4853335A (en) * 1987-09-28 1989-08-01 Olsen Duane A Colloidal gold particle concentration immunoassay
US5650333A (en) * 1990-12-24 1997-07-22 Nycomed Pharma As Immunoassay method and kit using superaggregated complex
US5292423A (en) * 1991-04-09 1994-03-08 New Mexico State University Technology Transfer Corp. Method and apparatus for trace metal testing
US5304359A (en) * 1992-03-03 1994-04-19 Bhp Minerals International Inc. Dissolution of platinum group metals from materials containing said metals
US5637508A (en) * 1993-03-26 1997-06-10 Geo-Centers, Inc. Biomolecules bound to polymer or copolymer coated catalytic inorganic particles, immunoassays using the same and kits containing the same
US5851777A (en) * 1996-02-05 1998-12-22 Dade Behring Inc. Homogeneous sol-sol assay
US6713308B1 (en) * 1999-05-05 2004-03-30 Fang Lu System for electrochemical quantitative analysis of analytes within a solid phase

Cited By (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20100320092A1 (en) * 2007-11-26 2010-12-23 The Secretary Of State For Innovation Universities And Skills Of Her Majesty's Britanni Electrochemical Detection of a Metal - Labelled Analyte
US8337692B2 (en) 2007-11-26 2012-12-25 The Secretary Of State For Innovation, Universities And Skills Of Her Majesty's Britannic Government Electrochemical detection of a metal—labelled analyte
US20110171735A1 (en) * 2008-07-10 2011-07-14 Robert Andrew Porter Apparatus and Methods for Effecting Chemical Assays
US8927299B2 (en) 2008-07-10 2015-01-06 The Secretary Of State For Innovation, Universities And Skills Of Her Majesty's Britannic Government Sample carrier for effecting chemical assays
GB2462062A (en) * 2008-07-14 2010-01-27 Sec Dep For Innovation Univers Electrochemical assay
US10232365B2 (en) 2012-09-28 2019-03-19 Agplus Diagnostics Ltd Test device and sample carrier
EP2796876A1 (en) * 2013-04-25 2014-10-29 Hasenkam ApS Strip for monitoring analyte concentrations
WO2014174085A1 (en) * 2013-04-25 2014-10-30 Hasenkam Aps Strip for monitoring analyte concentrations
US10094824B2 (en) 2013-04-25 2018-10-09 Hasenkam Aps Strip for monitoring analyte concentrations
WO2020000959A1 (en) * 2018-06-29 2020-01-02 北京华科泰生物技术股份有限公司 Electrochemical detection method based on marking with markers
EP3960291A1 (en) * 2020-08-28 2022-03-02 ETH Zurich In-situ controlled dissolution of metals using electrochemistry
WO2022043477A1 (en) * 2020-08-28 2022-03-03 Eth Zurich In-situ controlled dissolution of metals using electrochemistry

Also Published As

Publication number Publication date
CA2413929A1 (en) 2002-01-03
US20030186274A1 (en) 2003-10-02
WO2002001178A3 (en) 2003-02-13
DE60114016D1 (en) 2005-11-17
JP2004512496A (en) 2004-04-22
FR2810739B1 (en) 2007-01-26
CA2413929C (en) 2009-12-29
AU2001269256A1 (en) 2002-01-08
DE60114016T2 (en) 2006-06-22
JP4768202B2 (en) 2011-09-07
WO2002001178A2 (en) 2002-01-03
EP1303759B1 (en) 2005-10-12
ATE306670T1 (en) 2005-10-15
FR2810739A1 (en) 2001-12-28
US7045364B2 (en) 2006-05-16
EP1303759A2 (en) 2003-04-23

Similar Documents

Publication Publication Date Title
US7045364B2 (en) Electrochemical immunoassays using colloidal metal markers
US6713308B1 (en) System for electrochemical quantitative analysis of analytes within a solid phase
US8617907B2 (en) Determining the presence or amount of a metal-labelled species
US8404096B2 (en) Methods for producing highly sensitive potentiometric sensors
EP2005161B1 (en) Electrochemical sensor
Lv et al. Polyion oligonucleotide-decorated gold nanoparticles with tunable surface charge density for amplified signal output of potentiometric immunosensor
AU2002321531A1 (en) Methods for producing highly sensitive potentiometric sensors
WO2007116811A1 (en) Method for determination of substance
Wang et al. Electrochemical biosensor based on interdigitated electrodes for determination of thyroid stimulating hormone
US7176036B2 (en) Electroactive microspheres and methods
JP4915740B2 (en) Silver ion measurement method and test substance measurement method
Liu et al. A renewable electrochemical magnetic immunosensor based on gold nanoparticle labels
Roushani et al. The potentiality of graphene quantum dots functionalized by nitrogen and thiol-doped (GQDs-NS) to stabilize the antibodies in designing of human chorionic gonadotropin immunosensor
US20110024308A1 (en) Immunoassay
Krishnan et al. Fast amperometric immunoassay utilizing highly dispersed electrode material
Nguyen et al. Quantitative determination of triiodothyronine by electrochemical impedance spectroscopic biosensor using gold nanoparticle-modified electrode
Chikae et al. Highly sensitive method for electrochemical detection of silver nanoparticle labels in metalloimmunoassay with preoxidation/reduction signal enhancement
JPH09184842A (en) Conductive magnetic bead where physiologically active substance is immobilized
Tang et al. Potentiometric immunosensor based on immobilization of hepatitis B surface antibody on platinum electrode modified silver colloids and polyvinyl butyral as matrixes
Yu et al. An impedance biosensor array for label-free detection of multiple antigen-antibody reactions
Sun et al. Label-free electrochemical immunosensor for the determination of fetoprotein based on core-shell-shell nanocomposite particles

Legal Events

Date Code Title Description
STCB Information on status: application discontinuation

Free format text: ABANDONED -- FAILURE TO RESPOND TO AN OFFICE ACTION